Literature DB >> 20185784

Oxidative stress after thrombolysis-induced reperfusion in human stroke.

Carmen Domínguez1, Pilar Delgado, Angel Vilches, Pilar Martín-Gallán, Marc Ribó, Estevo Santamarina, Carlos Molina, Natalia Corbeto, Victor Rodríguez-Sureda, Anna Rosell, Jose Alvarez-Sabín, Joan Montaner.   

Abstract

BACKGROUND AND
PURPOSE: Animal models of transient ischemia suggest that oxygen-derived free radicals produced on reperfusion of ischemic brain could constitute the main cause of reperfusion injury. We aimed to determine the presence and role of lipid peroxidation and protein oxidation-related molecules after tissue plasminogen activator-induced recanalization in human stroke.
METHODS: A total of 160 patients with strokes involving the middle cerebral artery and treated with tissue plasminogen activator and 60 healthy controls were included. Blood samples, transcranial Doppler recordings, and National Institutes of Health Stroke Scale scores were obtained at baseline (pretreatment), 1 hour and 2 hours after tissue plasminogen activator bolus, and 12 hours and 24 hours after stroke onset. The main lipid peroxidation end-product malondialdehyde, advanced oxidation protein products, and plasma concentrations of myeloperoxidase were assessed.
RESULTS: At baseline, all oxidative stress biomarkers were higher than in control subjects (P<0.01 for all comparisons). Malondialdehyde remained high compared with controls during the study period, whereas myeloperoxidase concentrations were significantly raised at baseline, 1 hour after tissue plasminogen activator administration, and 12 hours after stroke onset. Malondialdehyde concentrations correlated with stroke severity and were associated with outcome and with hemorrhagic complications. Regarding recanalization, among those patients with middle cerebral artery recanalization by the end of tissue plasminogen activator infusion (44%) or anytime thereafter, no peaking of any of the studied molecules could be identified.
CONCLUSIONS: Our study showed that systemic oxidative damage to lipids and proteins had already occurred at baseline in stroke. In contrast to animal studies, a relationship between free radical-mediated oxidative damage to lipids or proteins and reperfusion injury after arterial recanalization could not be established.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185784     DOI: 10.1161/STROKEAHA.109.571935

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

Review 1.  Resveratrol neuroprotection in stroke and traumatic CNS injury.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2015-08-12       Impact factor: 3.921

Review 2.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling.

Authors:  Steven J Forrester; Daniel S Kikuchi; Marina S Hernandes; Qian Xu; Kathy K Griendling
Journal:  Circ Res       Date:  2018-03-16       Impact factor: 17.367

Review 3.  Neurocritical care of a reperfused brain.

Authors:  Aamir Badruddin; Muhammad A Taqi; Michael G Abraham; Dhimant Dani; Osama O Zaidat
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

4.  Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies.

Authors:  Lin L; Wang X; Yu Z
Journal:  Biochem Pharmacol (Los Angel)       Date:  2016-06-20

Review 5.  Ischemia-reperfusion injury in stroke.

Authors:  May Nour; Fabien Scalzo; David S Liebeskind
Journal:  Interv Neurol       Date:  2013-09

6.  Serum Levels of Thioredoxin Are Associated with Stroke Risk, Severity, and Lesion Volumes.

Authors:  Meng-Hai Wu; Fang-Yu Song; Li-Ping Wei; Zhao-Yun Meng; Zhi-Qiang Zhang; Qin-De Qi
Journal:  Mol Neurobiol       Date:  2014-12-19       Impact factor: 5.590

7.  Pilot results of in vivo brain glutathione measurements in stroke patients.

Authors:  Li An; Krishna A Dani; Jun Shen; Steven Warach
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-26       Impact factor: 6.200

8.  Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke.

Authors:  Svetlana Lorenzano; Natalia S Rost; Muhib Khan; Hua Li; Fabricio O Lima; Matthew B Maas; Rebecca E Green; Tijy K Thankachan; Allison J Dipietro; Ken Arai; Angel T Som; Loc-Duyen D Pham; Ona Wu; Gordon J Harris; Eng H Lo; Jeffrey B Blumberg; Paul E Milbury; Steven K Feske; Karen L Furie
Journal:  Stroke       Date:  2018-01-25       Impact factor: 7.914

9.  The Differences in the Cellular and Plasma Antioxidative Capacity Between Transient and Defined Focal Brain Ischemia: Does it Suggest Supporting Time-Dependent Neuroprotection Therapy?

Authors:  Srdjan Ljubisavljevic; Tatjana Cvetkovic; Lilika Zvezdanovic; Svetlana Stojanovic; Ivana Stojanovic; Gordana Kocic; Miroslava Zivkovic; Lidija Paunovic; Ljiljana Milenkovic; Dragisa Lukic; Jelena Stamenovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2015-09-03       Impact factor: 5.046

10.  Effects of Acute Stroke Serum on Non-Ischemic Cerebral and Mesenteric Vascular Function.

Authors:  Isabella Canavero; Helene A Sherburne; Sarah M Tremble; Wayne M Clark; Marilyn J Cipolla
Journal:  Transl Stroke Res       Date:  2016-01-26       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.